BenzingaAugust 18, 2026 at 6:56 AM NY17 days ago
Xylem Affirms Q3 Adj EPS Guidance of $1.42-$1.47 vs $1.46 Est; Affirms Q3 Sales Guidance of $2.300B vs $2.316B Est
Xylem (NYSE:XYL) affirms Q3 Adj EPS guidance from $1.42-$1.47 to $1.42-$1.47 vs $1.46 analyst estimate. Affirms Q3 sales outlook from $2.300 billion to $2.300 billion vs $2.316 billion estimate.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site — Benzinga
Companies in This Story
Related Stories
Jim Cramer Thinks This Struggling Stock Could See A “Big Earnings Acceleration”
Yahoo3 hours ago
Walmart, Target, and Kroger face growing retail crime issue
Yahoo3 hours ago
Cramer Says a Wave of 21 Year Olds on Robinhood Is the Only Reason This Market Has Not Cracked
Yahoo5 hours ago
Top Research Reports for Apple, Broadcom & Shell
Yahoo6 hours ago
Wall Street Has Cooled on Moderna After Its Stock Jumped Over 5X. But Does the mRNA Leader Have More Room to Run?
Yahoo6 hours ago